GT Biopharma, Inc. Quarterly Nonoperating Income (Expense) in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
GT Biopharma, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q2 2010 to Q3 2024.
  • GT Biopharma, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was $193K, a 72.7% decline year-over-year.
  • GT Biopharma, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was $1.42M, a 76.2% decline year-over-year.
  • GT Biopharma, Inc. annual Nonoperating Income (Expense) for 2023 was $5.98M, a 1503% increase from 2022.
  • GT Biopharma, Inc. annual Nonoperating Income (Expense) for 2022 was $373K.
  • GT Biopharma, Inc. annual Nonoperating Income (Expense) for 2021 was -$498K, a 97.7% increase from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $1.42M $193K -$513K -72.7% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 $1.93M $196K -$1.43M -88% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 $3.37M $825K -$2.61M -76% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $5.98M $206K +$12K +6.19% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-26
Q3 2023 $5.97M $706K +$564K +397% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 $5.4M $1.63M +$1.59M +4554% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 $3.81M $3.44M +$3.44M +171800% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 $373K $194K +$38K +24.4% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-26
Q3 2022 $335K $142K -$359K -71.7% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-01
Q2 2022 $694K $35K +$515K Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-07
Q1 2022 $179K $2K +$677K Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 -$498K $156K -$3.11M -95.2% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-30
Q3 2021 $2.61M $501K +$10.1M Jul 1, 2021 Sep 30, 2021 10-Q 2022-10-31
Q2 2021 -$7.46M -$480K +$15.4M +97% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 -$22.8M -$675K -$1.31M -206% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 -$21.5M $3.27M -$41.3M -92.7% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-28
Q3 2020 $19.8M -$9.57M +$11.4M +54.5% Jul 1, 2020 Sep 30, 2020 10-K 2021-04-16
Q2 2020 $8.33M -$15.9M -$15.4M -3011% Apr 1, 2020 Jun 30, 2020 10-K 2021-04-16
Q1 2020 $23.7M $638K +$1.09M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q4 2019 $22.6M $44.6M +$45.7M Oct 1, 2019 Dec 31, 2019 10-K 2021-04-16
Q3 2019 -$23.1M -$21M -$19.9M -1772% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-13
Q2 2019 -$3.23M -$510K +$3.41M +87% Apr 1, 2019 Jun 30, 2019 10-Q/A 2020-08-18
Q1 2019 -$6.64M -$454K +$2.48M +84.5% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-15
Q4 2018 -$9.12M -$1.14M -$1M -744% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-27
Q3 2018 -$8.11M -$1.12M +$2.65M +70.2% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 -$10.8M -$3.92M -$2.75M -233% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
Q1 2018 -$8.01M -$2.93M +$589K +16.7% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-15
Q4 2017 -$8.6M -$135K +$1.87M +93.3% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-29
Q3 2017 -$10.5M -$3.77M -$2.67M -243% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 -$7.81M -$1.18M -$4.84M -132% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 -$2.96M -$3.52M -$22.1M -119% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q4 2016 $19.1M -$2.01M +$21.2M +91.4% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-01
Q3 2016 -$2.06M -$1.1M -$2.19M -201% Jul 1, 2016 Sep 30, 2016 10-Q/A 2018-02-28
Q2 2016 $129K $3.66M -$24.6M -87% Apr 1, 2016 Jun 30, 2016 10-Q/A 2018-02-28
Q1 2016 $24.8M $18.6M +$37.3M Jan 1, 2016 Mar 31, 2016 10-Q/A 2018-02-28
Q4 2015 -$12.5M -$23.2M -$6.19M -36.4% Oct 1, 2015 Dec 31, 2015 10-K/A 2018-02-28
Q3 2015 -$6.34M $1.09M +$4.76M Jul 1, 2015 Sep 30, 2015 10-Q/A 2018-02-28
Q2 2015 -$11.1M $28.3M +$28.4M Apr 1, 2015 Jun 30, 2015 10-Q/A 2018-02-28
Q1 2015 -$39.5M -$18.7M -$18.4M -6854% Jan 1, 2015 Mar 31, 2015 10-Q/A 2018-02-28
Q4 2014 -$21.1M -$17M -$16.9M -11242% Oct 1, 2014 Dec 31, 2014 10-K/A 2018-02-28
Q3 2014 -$4.25M -$3.67M -$3.45M -1531% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-13
Q2 2014 -$801K -$157K +$68K +30.2% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-14
Q1 2014 -$869K -$269K -$1.1M -132% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-14
Q4 2013 $229K -$150K -$65K -76.5% Oct 1, 2013 Dec 31, 2013 10-K 2015-03-31
Q3 2013 $294K -$225K -$160K -246% Jul 1, 2013 Sep 30, 2013 10-Q 2014-12-17
Q2 2013 $454K -$225K +$1.15M +83.7% Apr 1, 2013 Jun 30, 2013 10-Q 2015-01-08
Q1 2013 -$699K $829K +$1.05M Jan 1, 2013 Mar 31, 2013 10-Q 2015-01-08
Q4 2012 -$1.75M -$85K +$5K +5.56% Oct 1, 2012 Dec 31, 2012 10-K 2015-01-08
Q3 2012 -$1.75M -$65K -$629K -112% Jul 1, 2012 Sep 30, 2012 10-Q 2014-12-17
Q2 2012 -$1.12M -$1.38M -$1.2M -661% Apr 1, 2012 Jun 30, 2012 10-Q 2014-12-12
Q1 2012 $74K -$219K -$154K -237% Jan 1, 2012 Mar 31, 2012 10-Q 2014-12-10
Q4 2011 $228K -$90K Oct 1, 2011 Dec 31, 2011 10-K 2014-11-18
Q3 2011 $564K +$543K +2586% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-21
Q2 2011 -$181K -$966K -123% Apr 1, 2011 Jun 30, 2011 10-Q/A 2012-09-13
Q1 2011 -$65K Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-21
Q3 2010 $21K Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-21
Q2 2010 $785K Apr 1, 2010 Jun 30, 2010 10-Q/A 2011-09-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.